Cencora

Cencora, formerly AmerisourceBergen, is a global pharmaceutical solutions organization. The company supports pharmaceutical manufacturers, healthcare providers and animal health businesses, and distributes prescription medicines through wholesale and specialty distribution networks. It employs more than 44,000 people across over 1,300 locations worldwide and reports annual revenue of more than $200 billion, placing it 11th on the Fortune 500. The firm rebranded to Cencora in August 2023.

Its work spans several technical domains: pharmaceutical distribution and supply-chain logistics, specialty pharmacy services, market access optimisation, animal health solutions and manufacturer services. Manufacturer support services are designed to help pharmaceutical innovators move therapies through the value chain to market. Provider services cover hospitals, specialty pharmacies, haemophilia treatment centres and home healthcare companies; the company states that it serves 100 per cent of U.S. hospitals. Animal health solutions serve veterinary providers worldwide.

Distribution sits at the centre of the business. Wholesale and specialty distribution operations are run to move medications reliably and securely to their destinations each day, a function that requires sustained work in logistics, quality, security and network operations. The company describes its purpose as improving access to healthcare for people and animals, and its stated emphasis is on the reliability, efficiency and security of medication delivery.